Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $105.40 | Total: $527.00 |
| 1 | 10 | $89.28 | Total: $892.80 |
| 1 | 25 | $75.64 | Total: $1,891.00 |
| 1 | 50 | $64.48 | Total: $3,224.00 |
| 1 | 100 | $55.80 | Total: $5,580.00 |
Overview
Eldacimibe (WAY-ACA-147) is an ACAT2 inhibitor for the treatment of cardiovascular disease and endocrine and metabolic disorders, study of atherosclerosis and hypercholesterolemia.
Chemical Properties
| Molecular Formula | C39H58N2O5 |
| Molecular Weight | 634.89 |
| CAS Numbers | 141993-70-6 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(N(CC1=CC=C(CC(C)(C)C)C=C1)CCCCCC)(NC2=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C2)=C3C(=O)OC(C)(C)OC3=O |
Storage and Handling
0C Short Term, -20C Long Term
References
Siegfried Hekimi, et al. Acat inhibitors and their use in the prevention or treatment of fibrosis. WO2008058383A1.